Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a Chinese Population

NCT05370560 is registered in ClinicalTrials.gov with Liegang Liu as lead sponsor.

NCT NCT05370560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05370560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a Chinese Population
Lead sponsor
Liegang Liu
Phase
Observational
Overall status
Completed
Start date
December 1, 2010
Completion date
June 30, 2020
Enrollment
3,325 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

impaired glucose regulation, type 2 diabetes